Frankfurt - Delayed Quote EUR
Insulet Corporation (GOV.F)
263.40
+2.40
+(0.92%)
At close: June 13 at 9:55:01 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 19 | 19 | 23 | 23 |
Avg. Estimate | 612.13M | 644.73M | 2.52B | 2.96B |
Low Estimate | 576.2M | 627.7M | 2.43B | 2.83B |
High Estimate | 619M | 659.63M | 2.57B | 3.1B |
Year Ago Sales | 488.5M | 543.9M | 2.07B | 2.52B |
Sales Growth (year/est) | 25.31% | 18.54% | 21.63% | 17.64% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
GOV.F | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Upgrades & Downgrades
Initiated | Goldman Sachs: Buy | 5/30/2025 |
Maintains | Raymond James: Outperform to Outperform | 5/27/2025 |
Maintains | Citigroup: Buy to Buy | 5/22/2025 |
Upgrade | Wolfe Research: Peer Perform to Outperform | 5/13/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 5/9/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 4/30/2025 |